Page last updated: 2024-10-27

flunitrazepam and Carcinoma, Hepatocellular

flunitrazepam has been researched along with Carcinoma, Hepatocellular in 1 studies

Flunitrazepam: A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug.
flunitrazepam : A 1,4-benzodiazepinone that is nitrazepam substituted by a methyl group at position 1 and by a fluoro group at position 2'. It is a potent hypnotic, sedative, and amnestic drug used to treat chronic insomnia.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peng, FC1
Chaing, HH1
Tang, SH1
Chen, PC1
Lu, SC1

Other Studies

1 other study available for flunitrazepam and Carcinoma, Hepatocellular

ArticleYear
NADPH-cytochrome P-450 reductase is involved in flunitrazepam reductive metabolism in Hep G2 and Hep 3B cells.
    Journal of toxicology and environmental health. Part A, 2004, Jan-23, Volume: 67, Issue:2

    Topics: Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Flunitrazepam; GABA Modulators; Humans;

2004